Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients.
Hye Yeon ChonSang Hoon AhnYoon Jun KimJung-Hwan YoonJeong-Hoon LeeDong Hyun SinnSeung-Up KimPublished in: Hepatology international (2021)
The outcomes of ETV, TDF, and TAF on the risk of HCC and OLT or mortality were statistically similar in treatment-naïve patients with CHB.
Keyphrases
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- acute lymphoblastic leukemia
- cardiovascular events
- prognostic factors
- type diabetes
- peritoneal dialysis
- combination therapy
- coronary artery disease
- antiretroviral therapy
- patient reported outcomes
- replacement therapy
- smoking cessation